Correlation between systolic function and presence of myofibroblasts in doxorubicin-induced cardiomyopathy

Cardiotoxicity induced by doroxubicin generates systolic disfunction and myocardial remodeling with presence of myofibroblasts. These cells are thought to be attracted to the injured heart to avoid the development of congestive heart failure. The objective of this study was to evaluate the systolic dysfunction generated by doxorubicin through Doppler echocardiography, and its correlation with the presence of myofibroblasts in the myocardium. Twenty-five New Zealand White rabbits were divided into two groups (control, and treated with doxorubicin). The drug was administered for six weeks; Doppler echocardiography was performed before the first, and after the last administration of doxorubicin. Immuno detection of myofibroblasts was performed by immunohistochemistry. The treated group exhibited significant reduction in systolic function as assessed by Doppler echocardiography, and increased frequency of myofibroblasts, which were present in similar amounts in the left ventricle, interventricular septum, and right ventricle. There was a significant negative correlation between number of myofibroblasts in the interventricular septum and in the left ventricle with systolic function indices, which reveals that the higher the number of fibroblasts, the worst systolic function is in rabbits treated with doxorubicin. Increase in myofibroblast numbers was not sufficient to preserve systolic function.

[1]  J. C. Barbosa,et al.  Doxorubicin-induced dilated cardiomyopathy in a rabbit model: an update , 2012 .

[2]  Wei Liu,et al.  Autologous bone marrow mesenchymal cell transplantation improves left ventricular function in a rabbit model of dilated cardiomyopathy. , 2010, Experimental and molecular pathology.

[3]  J. Gummert,et al.  Changes in extra cellular matrix remodelling and re-expression of fibronectin and tenascin-C splicing variants in human myocardial tissue of the right atrial auricle: implications for a targeted therapy of cardiovascular diseases using human SIP format antibodies , 2010, Journal of Molecular Histology.

[4]  S. Clément,et al.  Modulation of actin isoform expression before the transition from experimental compensated pressure-overload cardiac hypertrophy to decompensation. , 2009, American journal of physiology. Heart and circulatory physiology.

[5]  R. Else,et al.  Distribution of myofibroblasts, smooth muscle-like cells, macrophages, and mast cells in mitral valve leaflets of dogs with myxomatous mitral valve disease. , 2008, American journal of veterinary research.

[6]  Lars Eckardt,et al.  Doppler echocardiography and tissue Doppler imaging in the healthy rabbit: differences of cardiac function during awake and anaesthetised examination. , 2007, International journal of cardiology.

[7]  A. A. Camacho,et al.  Neurohormonal, hemodynamic, and electrocardiographic evaluations of healthy dogs receiving long-term administration of doxorubicin. , 2006, American journal of veterinary research.

[8]  P. Schirmacher,et al.  Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end‐stage dilated, ischaemic and valvular cardiomyopathy , 2006, Histopathology.

[9]  S. Hagl,et al.  Extracellular matrix proteins and matrix metalloproteinases differ between various right and left ventricular sites in end-stage cardiomyopathies , 2005, Virchows Archiv.

[10]  P. Insel,et al.  Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Tidholm,et al.  Histologic Characterization of Canine Dilated Cardiomyopathy , 2005, Veterinary pathology.

[12]  C. Leeuwenburgh,et al.  Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis. , 2002, Biochimica et biophysica acta.

[13]  H. Crijns,et al.  Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables , 1999, Heart.

[14]  Y. Toyoda,et al.  A canine model of dilated cardiomyopathy induced by repetitive intracoronary doxorubicin administration. , 1998, The Journal of thoracic and cardiovascular surgery.

[15]  W. Liu,et al.  [The expression of proliferating cell nuclear antigen and alpha smooth muscle actin in papillary muscles of the patient with rheumatic heart disease and its significance]. , 1998, Zhonghua yi xue za zhi.

[16]  M. Daemen,et al.  The alpha-smooth muscle actin-positive cells in healing human myocardial scars. , 1994, The American journal of pathology.

[17]  C. Terzano,et al.  Do we have two hearts? New insights in right ventricular function supported by myocardial imaging echocardiography , 2009, Heart Failure Reviews.

[18]  中村 右子,et al.  Cx43 contributes to TGF-β signaling to regulate differentiation of cardiac fibroblasts into myofibroblasts , 2009 .

[19]  M. Dias,et al.  Estudo de um modelo animal de hipoplasia sanguinea induzida pelo agente antineoplasico doxorrubicina (Adriblastina) , 2003 .

[20]  Carlos Alberto Mandarim-de-Lacerda,et al.  Reparação Miocárdica quando em Uso de Baixa Dosagem e Longa Duração de Inibidor da Síntese do Óxido Nítrico. Miofibroblastos, Colágeno Tipo III e Fibronectina , 1999 .